. Author manuscript; available in PMC: 2014 Oct 7.

Published in final edited form as: J Am Vet Med Assoc. 2011 Apr 1;238(7):915–921. doi: 10.2460/javma.238.7.915

Table 1.

Comparison of median (range) SBP measurements (mm Hg) and number of ocular lesions in 37 hypertensive dogs^* receiving and not receiving drugs to treat hypertension

			No lesions		1 lesion		≥ 2 lesions
Variable	No. of dogs	SBP	No. of dogs (%)	SBP	No. of dogs (%)	SBP	No. of dogs (%)	SBP
AHTD	15	190 (166–236)	5/15 (33)	185 (173–202)	4/15 (27)	210 (166–253)	6/15 (40)	190 (174–263)
No AHTD	22	201 (165–265)	9/22 (41)	191 (165–210)	7/22 (32)	219 (165–263)	6/22 (27)	193 (168–265)
P value^†	NA	0.78	0.75	0.84	0.73	0.93	0.49	0.57

Of the 42 hypertensive dogs in this study, 5 that received phenylpropanolamine were excluded from this analysis.

^†

Neither median SBP nor the number of ocular lesions was significantly (P < 0.05) associated with treatment status.

AHTD = Antihypertensive drugs. NA = Not applicable.